Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of gefitinib

A technology of gefitinib and compounds, which is applied in the field of innovative drug preparation, can solve the problems of chlorination pollution, long total route, etc., and achieve the effects of low environmental pollution, simple post-processing, safe, reliable and stable product quality

Inactive Publication Date: 2013-09-18
LIANYUNGANG SHENGHE BIOTECH
View PDF9 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] This route undergoes reactions such as hydrocarbylation, nitration, reduction, ring closure, and chlorination. The total route is long and far from expensive, and the chlorination process is polluted.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of gefitinib
  • Preparation method of gefitinib

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Embodiment 1, a kind of preparation method of gefitinib, this method comprises the steps:

[0034] (1) Using 3-hydroxy-4-methoxybenzocyanide and 4-(3-chloropropyl)morpholine as raw materials, react under the action of an appropriate solvent and base to prepare compound 1, namely 4-(3- Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline;

[0035] (2) Compound 1 was nitrated to obtain compound 2, methyl 2-nitro-4-methoxy-5-[3-(4-morpholinyl)propoxy]benzoate;

[0036] (3) Compound 2 was reduced to obtain compound 3, namely methyl 2-amino-4-methoxy-5-[3-(4-morpholinyl)propoxy]benzoate;

[0037] (4) React 3-chloro-4-fluoroaniline with N,N-dimethylformamide dimethyl acetal to obtain compound 4, namely (3-chloro-4-fluorophenyl)-N,N-dimethyl dimethylimine;

[0038] (5) Ring closure of compound 3 and compound 4 in a solvent to obtain gefitinib.

Embodiment 2

[0039] Example 2, the preparation method of gefitinib described in Example 1, in step (1): the reaction solvent is selected from dimethyl sulfoxide, dimethylformamide, dimethylacetamide, toluene and dimethicone One or more mixtures of toluene; the base is an inorganic base or an organic base, wherein: the inorganic base is selected from sodium carbonate, sodium bicarbonate, potassium carbonate, and potassium bicarbonate; The base is one or a mixture of trimethylamine, triethylamine, tripropylamine and tri-n-butylamine.

Embodiment 3

[0040] Embodiment 3, the preparation method of gefitinib described in embodiment 1 or 2, in step (2): the mass fraction of nitric acid is 50%-85%; The reaction time is 1-24 hours, and the reaction temperature is 0 -80°C.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a preparation method of gefitinib. The preparation method comprises the following steps of: reacting under the action of an appropriate solvent and alkali by taking 3-hydroxy-4-methoxybenzonitrile and 4-(3-chloropropyl) morpholine as raw materials to prepare 4-(3-chlorine-4-fluorophenyl amido)-7-methoxyl-6-[3-(4-morpholinyl)propoxy] quinazoline; nitrifying the 4-(3-chlorine-4-fluorophenyl amido)-7-methoxyl-6-[3-(4-morpholinyl)propoxy] quinazoline to obtain 2-nitryl-4-methoxyl-5-[3-(4-morpholinyl)propoxy] methyl benzoate, and then reducing the 2-nitryl-4-methoxyl-5-[3-(4-morpholinyl)propoxy] methyl benzoate to obtain 2-amido-4-methoxyl-5-[3-(4-morpholinyl)propoxy] methyl benzoate; reacting 3-chlorine-4-fluoroaniline with N,N-dimethylformamide dimethylacetal to obtain (3-chlorine-4-fluorophenyl)-N,N-dimethyl dimethyleneimine; and carrying out loop closing on the 2-amido-4-methoxyl-5-[3-(4-morpholinyl)propoxy] methyl benzoate and the (3-chlorine-4-fluorophenyl)-N,N-dimethyl dimethyleneimine to obtain the gefitinib. The preparation method disclosed by the invention has the advantages of short process route, safety and easiness for operation, easiness and convenience for post processing, high reduction transformation ratio and yield, less environment pollution, and safety, reliability and stability in product quality.

Description

technical field [0001] The invention relates to a method for synthesizing anticancer drugs, in particular to a method for preparing gefitinib, and belongs to the technical field of innovative drug preparation. Background technique [0002] Gefitinib is an orally available small molecule inhibitor of EGFR tyrosine kinase developed by Astra Zeneca. In 2002, it was first launched in Japan for the treatment of inoperable or recurrent non-small cell lung cancer. In May 2003, it was approved in the United States and Australia as a third-line monotherapy for advanced non-small cell lung cancer. It is the first treatment for solid cancer Small molecule tyrosinase inhibitors targeting specific targets. Approved by the State Food and Drug Administration on February 25, 2005, it was officially launched in China for the treatment of locally advanced or metastatic non-small cell lung cancer who have previously received chemotherapy. [0003] The current technology of gefitinib mainly i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D239/94
Inventor 张久彦严飞飞张辉毛庆磊秦宁傅咏梅
Owner LIANYUNGANG SHENGHE BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com